These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 29382616
1. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases. Zhang GJ, Zhang GB, Zhang YS, Li H, Li CB, Zhang LW, Li D, Wu Z, Zhang JT. World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616 [Abstract] [Full Text] [Related]
2. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Cancer; 2012 Feb 15; 118(4):1048-54. PubMed ID: 21773968 [Abstract] [Full Text] [Related]
3. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas. Li D, Jiang P, Xu S, Li C, Xi S, Zhang J, Chen Y, Jiang X, Zhang X, Sai K, Wang J, Mou Y, Ke C, Chen Z. J Neurooncol; 2019 Oct 15; 145(1):125-134. PubMed ID: 31493161 [Abstract] [Full Text] [Related]
4. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. World Neurosurg; 2017 Jul 15; 103():655-663. PubMed ID: 28450233 [Abstract] [Full Text] [Related]
5. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment. Liu X, Shan B, Wang M, Xu J. World Neurosurg; 2018 Jan 15; 109():e352-e362. PubMed ID: 28987849 [Abstract] [Full Text] [Related]
6. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas. Tao X, Dong J, Hou Z, Hao S, Zhang J, Wu Z, Liu B. World Neurosurg; 2018 Mar 15; 111():e880-e887. PubMed ID: 29325940 [Abstract] [Full Text] [Related]
8. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment. Champeaux C, Dunn L. World Neurosurg; 2016 May 15; 89():180-6. PubMed ID: 26850975 [Abstract] [Full Text] [Related]
9. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. Keric N, Kalasauskas D, Freyschlag CF, Gempt J, Misch M, Poplawski A, Lange N, Ayyad A, Thomé C, Vajkoczy P, Meyer B, Ringel F. J Neurooncol; 2020 Jan 15; 146(2):347-355. PubMed ID: 31900826 [Abstract] [Full Text] [Related]
10. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution. Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y. J Neurosurg; 2018 Jun 15; 128(6):1698-1706. PubMed ID: 28820306 [Abstract] [Full Text] [Related]
14. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases. Wang XQ, Jiang CC, Zhao L, Gong Y, Hu J, Chen H. J Neurosurg Pediatr; 2012 Nov 15; 10(5):423-33. PubMed ID: 22938082 [Abstract] [Full Text] [Related]
15. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma. Choi Y, Lim DH, Yu JI, Jo K, Nam DH, Seol HJ, Lee JI, Kong DS, Suh YL, Nam H. Am J Clin Oncol; 2018 Jan 15; 41(1):18-23. PubMed ID: 26270441 [Abstract] [Full Text] [Related]
16. Rhabdoid meningiomas: Clinicopathological analysis of a rare variant of meningioma. Birua GJS, Sadashiva N, Konar S, Rao S, Shukla D, Krishna U, Saini J, Santosh V. Clin Neurol Neurosurg; 2021 Aug 15; 207():106778. PubMed ID: 34214868 [Abstract] [Full Text] [Related]
18. WHO grade II and III meningiomas: a study of prognostic factors. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamaridès M, Menei P, Deruty R, Moreau JJ, Fèvre-Montange M, Guyotat J. J Neurooncol; 2009 Dec 15; 95(3):367-375. PubMed ID: 19562258 [Abstract] [Full Text] [Related]